AI-assisted editorial guide · Published November 20, 2026
LifeX’s current information is now hosted through the Pittsburgh Life Sciences Alliance. The page reviewed November 20, 2026 states that the organizations combined in October 2026, updated programs are coming soon and program applications are not yet available. It offers a company-introduction route and distinguishes investment enquiries. Use that current page rather than an older accelerator announcement when deciding how to make contact.
State the company’s stage and immediate question
Describe the venture, its development stage and the business decision it is preparing for. Keep a research concept, validated prototype and commercially available product distinguishable. A life-science company may need introductions, commercialization support or a discussion about a future program, but those are different requests. This guide addresses the introduction record; it does not assess clinical evidence, regulatory readiness or investment suitability.
Use the current organization and contact route
The current page explains why an older LifeX link leads to PLSA. Save that reference and the date checked. Do not assume that a former cohort’s format, eligibility or timetable remains available after the organizational change. The page says updated programs are not yet open for application. A company-introduction form is not the same as acceptance into a program.
Separate investment from support-program interest
The current information distinguishes investment enquiries from forthcoming programs. Identify the purpose of your contact and ask which route applies. An introduction, meeting or submitted form does not establish investor interest or a funding commitment. Keep any requested financial information within the appropriate process and preserve the terms actually provided rather than relying on a historical description of the organization.
Prepare a nonconfidential business summary
Explain the problem, intended customer, team responsibilities and the type of help sought without disclosing protected technical detail unnecessarily. Identify whether intellectual-property or institutional permissions need a separate review before more information is shared. A fictional university-origin venture might describe its commercialization question while marking licensing matters unresolved. Do not present a planned license or regulatory milestone as completed merely to make the introduction sound more advanced.
List the next milestone and its evidence
Choose a concrete business milestone and distinguish completed work from assumptions. This could be a customer-discovery step, a commercialization planning question or preparation for an appropriate professional review. Do not use this guide to claim that a product is safe, effective, approved or ready for investment. The purpose is to explain the company accurately enough for the organization to assess the next conversation.
Keep the response and current availability together
Record what the organization actually offers, the information requested and any later announcement about programs. If the answer is to wait for updated opportunities, preserve that status rather than describing the company as enrolled. Review the official page again before acting on old notes. A current, factual introduction is more useful than an application package built around a program that has changed.
Prepare a focused next step
- Company stage and business question
- Current PLSA contact route
- Program versus investment enquiry
- Nonconfidential summary and permissions
- Next milestone and verified response
Sources and review scope
Public guidance checked November 20, 2026. These are editorial planning questions, not a provider ranking, an inspection, or a determination of legal or permit requirements for your project.
Continue your research
Directory entries provide a starting point for research. They do not establish current service availability, a credential, insurance coverage, or an endorsement. Confirm material details with the provider and the appropriate authority.